ArticleJournal of proteomics2018

Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib.

Simon Vyse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.